Cardiotoxicity From the cardiologist’s Perspective

References

• Albini A , PennesiG, DonatelliF, CammarotaR, De FloraS, NoonanDM . Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention . J. Natl Cancer Inst.102 ( 1 ), 14 – 25 ( 2010 ).
   PubMedGoogle Scholar
• Herrmann J , LermanA, SandhuNPet al. Evaluation and management of patients with heart disease and cancer: cardio-oncology . Mayo Clin. Proc.89 ( 9 ), 1287 – 1306 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Sawyer D . Anthracyclines and heart failure . N. Engl. J. Med.368 ( 12 ), 1154 – 1156 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Guarneri V , LenihanDJ, ValeroVet al. Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the MD Anderson cancer center experience . J. Clin. Oncol.24 ( 25 ), 4107 – 4115 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Polk A1 , VistisenK, Vaage-NilsenM, NielsenDL . A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity . BMC Pharmacol. Toxicol.15, 47 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Choueiri TK , MayerEL, JeYet al. Congestive heart failure risk in patients with breast cancer treated with bevacizumab . J. Clin. Oncol.29 ( 6 ), 632 – 638 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Greineder CF , KohnstammS, KyB . Heart failure associated with sunitinib: lessons learned from animal models . Curr. Hypertens. Rep.13 ( 6 ), 436 – 441 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Plana JC , GalderisiM, BaracAet al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging . J. Am. Soc. Echocardiogr.27 ( 9 ), 911 – 939 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Kou S , CaballeroL, DulgheruRet al. Echocardiographic reference ranges for normal cardiac chamber size: results from the NORRE study . Eur. Heart J. Cardiovasc. Imaging15 ( 6 ), 680 – 690 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lang R , BadanoL, Mor-AviVet al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging . J. Am. Soc. Echocardiogr.28 ( 1 ), 1 – 39 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ewer MS , LippmanSM . Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity . J. Clin. Oncol.23 ( 13 ), 2900 – 2902 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Lal H , KolajaK, ForceT . Cancer genetics and the cardiotoxicity of the therapeutics . J. Am. Coll. Cardiol.61 ( 3 ), 267 – 274 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Cardinale D , ColomboA, LamantiaGet al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy . J. Am. Coll. Cardiol.55 ( 3 ), 213 – 220 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Hudis CA . Trastuzumab – mechanism of action and use in clinical practice . N. Engl. J. Med.357 ( 1 ), 39 – 51 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Oreto L , TodaroMC, UmlandMMet al. Use of echocardiography to evaluate the cardiac effects of therapies used in cancer treatment: what do we know? J. Am. Soc. Echocardiogr. 25 ( 11 ), 1141 – 1152 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Daher IN , KimC, SalehRR, PlanaJC, YusufSW, BanchsJ . Prevalence of abnormal echocardiographic findings in cancer patients: a retrospective evaluation of echocardiography for identifying cardiac abnormalities in cancer patients . Echocardiography28 ( 10 ), 1061 – 1067 ( 2010 ).
   Web of Science ®Google Scholar
• Senior R , BecherH, MonaghanMet al. Contrast echocardiography: evidence based recommendations by European Association of Echocardiography . Eur. J. Echocardiogr.10 ( 2 ), 194 – 212 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Lang R , Mor-AviV, DentJM, KramerCM . Three-dimensional echocardiography: is it ready for everyday clinical use?JACC Cardiovasc. Imaging2 ( 1 ), 114 – 117 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Badano L , BoccaliniF, MuraruDet al. Current clinical applications of transthoracic three-dimensional echocardiography . J. Cardiovasc. Ultrasound20 ( 1 ), 1 – 22 ( 2012 ).
   PubMedGoogle Scholar
• Lang R , BadanoL, TsangWet al. EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography . J. Am. Soc. Echocardiogr.25 ( 1 ), 3 – 46 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Thavendiranathan P , GrantAD, NegishiT, PlanaJC, PopovivZB, MarwickTH . Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes application to patients undergoing cancer chemotherapy . J. Am. Coll. Cardiol.61 ( 1 ), 77 – 84 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Mor-Avi V , LangR, BadanoLet al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography . J. Am. Soc. Echocardiogr.24 ( 3 ), 277 – 313 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Yingchoncharoen T , AgarwalS, PopoviZ B, MarwickTH . Normal ranges of left ventricular strain: a meta-analysis . J. Am. Soc. Echocardiogr.26 ( 2 ), 185 – 191 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kang Y , XuX, ChengLet al. Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy . Eur. J. Heart Fail.16 ( 3 ), 300 – 308 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Thavendiranathan P , PoulinF, LimKD, PlanaJC, WooA, MarwickTH . Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy – a systematic review . J. Am. Coll. Cardiol.63 ( 25PtA ), 2751 – 2768 ( 2014 ).
   PubMedGoogle Scholar
• Colombo A , SandriM, SalvaticiM, CipollaC, CardinaleD . Cardiac complications of chemotherapy: role of biomarkers . Curr. Treat. Options Cardiovasc. Med.16 ( 6 ), 313 ( 2014 ).
   PubMedGoogle Scholar
• Lancellotti P , NkomoVT, BadanoLet al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography . J. Am. Soc. Echocardiogr.26 ( 9 ), 1013 – 1032 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Darby SC , EwertzM, McGalePet al. Risk of ischemic heart disease in women after radiotherapy for breast cancer . N. Engl. J. Med.368 ( 11 ), 987 – 998 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Truong J , YanAT, CramarossaG, ChanKK . Chemotherapy-induced cardiotoxicity: detection, prevention, and management . Can. J. Cardiol.30 ( 8 ), 869 – 878 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Borras J M , AlbrehtT, AudisioRet al. European policy statement on multidisciplinary cancer care. European Partnership Action Against Cancer: Consensus group . Eur. J. Cancer.50 ( 3 ), 475 – 480 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Eschenhagen T , ForceT, EwerMSet al. Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology . Eur. J. Heart Fail.13 ( 1 ), 1 – 10 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Yancy C W , JessupM, BozkurtBet al. 2013 ACCF/AHA heart failure guidelines: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines . J. Am. Coll. Cardiol.62 ( 16 ), 1495 – 1539 ( 2013 ).
   Web of Science ®Google Scholar
• Bosch X , RoviraM, SitgesMet al. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies) . J. Am. Coll. Cardiol.61 ( 23 ), 2355 – 2362 ( 2013 ).
   PubMed Web of Science ®Google Scholar